asa guidelines for glp-1 glp 1 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists Drugs: 2025 Pulse Survey – Perioperative Management of GLP-1 RAs

This is one further example by which there continues to be gaps in the literature surrounding this topic and where studies can explore more avenues to find potential solutions

In research settings, Ipamorelin is used to stimulate biological pathways involved in growth hormone secretion

A bit of extra energy keeps you consistent in training, and consistency is what brings results

Building on the understanding that GLP-1 agonists induce weight loss through appetite suppression and slowed gastric emptying, it is crucial to recognize the potential downstream consequences of these mechanisms, particularly regarding nutritional status